Venturi Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-100
Closed -$2.35K – 649
2024
Q4
$2.35K Hold
100
– – ﹤0.01% 1829
2024
Q3
$2.56K Hold
100
– – ﹤0.01% 1628
2024
Q2
$2.35K Sell
100
-39
-28% -$984 ﹤0.01% 1345
2024
Q1
$4K Sell
139
-41
-23% -$1.23K ﹤0.01% 1140
2023
Q4
$5.91K Buy
180
+4
+2% +$109 ﹤0.01% 998
2023
Q3
$4.9K Sell
176
-44
-20% -$1.44K ﹤0.01% 989
2023
Q2
$7.5K Buy
220
+44
+25% +$1.38K ﹤0.01% 693
2023
Q1
$5.29K Buy
+176
New +$5.45K ﹤0.01% 814

Other funds holding ARKG

Venturi Wealth Management's ARKG Position: Q1 2025 in Review

Venturi Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 100 shares — an estimated $2.35K sold.

Venturi Wealth Management first reported a position in ARKG in Q1 2023 and held it in 8 quarters. The position peaked at $7.5K in Q2 2023. 217 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

  • Venturi Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 100 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $2.35K.
  • Venturi Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2023 and held it in 8 quarters.
  • Venturi Wealth Management's ARK Genomic Revolution ETF position peaked at $7.5K in Q2 2023.
  • 217 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.